Cd8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: Development of Hla-Dr+ Cd38 Cd8+ cells is associated with subsequent stable Cd4+ cell levels

Journal of Infectious Diseases

Volumn 170, Issue 4, 1994, Pages 775-781

  Giorgi, Janis V ^a,b,c,d,e   Ho, Hong Nerng ^a,b,c,d,e,f   Hirji, Karim ^a,b,c,d,e   Chou, Chen Cheng ^a,b,c,d,e,f   Hultin, Lance E ^a,b,c,d,e   O’rourke, Sheryl ^a,b,c,d,e   Park, Lawrence ^a,b,c,d,e   Margolick, Joseph B ^a,b,c,d,e   Ferbas, John ^a,b,c,d,e   Phair, John P ^a,b,c,d,e   Saah, A J ^c   Armenian, H ^c   Farzadegan, H ^c   Graham, N ^c   Mc Arthur, J ^c   Margolick, J B ^c   Palenicek, J ^c   Muaoz A ^c   Hoover, D ^c   Galai, N ^c   Jacobson, L P ^c   Park, L ^c   Piantadosi, S ^c   Su, S ^c   Phair, J P ^e   Bauer, K ^e   Chmiel, J S ^e   Cohen, B ^e   Variakojis, D ^e   Wesch, J ^e   Wolinsky, S M ^e   Detels, R ^b   Visscher, B R ^b   Chen, I ^b   Dudley, J ^b   Fahey, J L ^b   Ferbas, J ^b   Giorgi, J V ^b   Martinez Maza, O ^b   Nishanian, P ^b   Taylor, J ^b   Zack, J ^b   Rinaldo, C R ^d   Becker, J T ^d   Gupta, P ^d   Ho, M ^d   Kingsley, L ^d   Schrager, L ^g   Kaslow, R A ^g   Van Raden, M J ^g   Seminara, D ^g   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HELPER CELL; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; SEROCONVERSION; SUPPRESSOR CELL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BISEXUALITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HLA-DR ANTIGENS; HOMOSEXUALITY, MALE; HUMAN; LYMPHOCYTE ACTIVATION; MALE; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; T-LYMPHOCYTE SUBSETS; TIME FACTORS;

EID: 0027965585     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.4.775     Document Type: Article

References (29)

1. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multitenter AIDS Cohort Study. Clin Immunol Immunopathol 1989;52:10-8.
2. Salazar-Gonzalez JF, Moody DJ, Giorgi JV, Martinez-Maza O. Mitsuyasu RT. Fahey JL. Reduced ecto-.V-nucleotidase activity and enhanced OKTIO and HLA-DR expression on CD8 (T-suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: Evidence of CD8 cell immaturity. J Immunol 1985; 135:1778-85.
3. Lang W, Perkins H. Anderson RF„ Royce R, Jewell N, Winkelstein W Jr. Patterns ofT lymphocyte changes with human immunodeficiency virus infection: From seroconversion to the development of AIDS. J AIDS 1989;2:63-9.
4. Cooper DA. Tindall B. Wilson EJ. Imrie AA. Penny R. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. J Infect Dis 1988;157:889-96.
5. Yagi MJ, Joesten MH. Wallace J, Roboz JP, Bekesi JG. Human immunodeficiency virus type 1 (HIV-1) genomic sequences and distinct changes in CD8+ lymphocytes precede detectable levels of HIV-1 antibodies in high-risk homosexuals. J Infect Dis 1991;164:183-8.
6. Autran B, Giorgi JV. Activated CD8+ cells in HIV-related diseases. In: Janossy G, Autran B, Miedema F. eds. Immunodeficiency in HIV infection and AIDS. Basel. Switzerland: Karger, 1992:171-84.
7. Ho HN, Hultin LF., Mitsuyasu RT. et al. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol 1993;150:3070-9.
8. Giorgi J V, Liu Z. Hultin LE, Cumberland WG. Hennessey K. Detels R. Elevated levels of CD38+CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: Results of 6 years of follow-up. J AIDS 1993;6:904-12.
9. Levacher M, Hulstaert F, Tallet S. Ullery S. Pocidalo JJ. Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: Staging and prognostic value. Clin Exp Immunol 1992;90:376-82.
10. Evans RL. Faldetta TJ. Humphreys RE. Pratt DM, Yunis EJ, Schloss-man SF. Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express la-like antigens. J Exp Med 1978;148:1440-5.
11. Hercend T, Ritz J, Schlossman SF Reinherz EL. Comparative expression of T9, T10, and la antigens on activated human T cell subsets. Hum Immunol 1981;3:247-59.
12. Jackson DG, Bell JI. Isolation of a cDNA encoding the human CD38 (TIO) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol 1990;144:2811-5.
13. Funaro A, Spagnoli GC, Ausiello CM, et al. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol 1990;145:2390-6.
14. Walker CM, Moody DJ, Stites DP. Levy JA. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-6.
15. Brinchmann JE, Gaudernack G, Vartdal F. CD8+ T cells inhibit HIV replication in naturally infected C'D4+ T cells: Evidence fora soluble inhibitor. J Immunol 1990;144:2961-6.
16. Hausner MA, Giorgi JV, Plaeger-Marshall S. A reproducible method to detect CD8 T cell mediated inhibition of HIV production from naturally infected CD4 cells. J Immunol Methods 1993;157:181-7.
17. Walker BD, Flexner C, Birch-Limberger K, et al. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type I. Proc Natl Acad Sci USA 1989;86:9514-8.
18. Nixon DF, McMichael AJ. Cytotoxic T-cell recognition of HIV proteins and peptides. AIDS 1991;5:1049-59.
19. Polk BF, Fox R. Brookmeyer R, et al. Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987;316:61-6.
20. Kaslow RA. Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR. The Multicenter AIDS Cohort Study: Rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
21. Moss AR, Bacchetti P. Natural history of HIV infection. AIDS 1989;3:55-61.
22. Taylor JMG. Fahey JL, Detels R, Giorgi JV. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: Which to choose and how to use. J AIDS 1989;2:114-24.
23. Nishanian P, Taylor JMG, Korns E, Detels R, Saah A, Fahey JL. Significance of quantitative enzyme-linked immunosorbent assay (ELISA) results in evaluation of three ELISAs and Western blot tests for detection of antibodies to human immunodeficiency virus in a high-risk population. J Clin Microbiol 1987;25:395-400.
24. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990;300:230-5.
25. Phair J, Jacobson L, Detels R. et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The Multicenter AIDS Cohort Study. J AIDS 1992;5:490-6.
26. Lifson AR, Buchbinder SP, Sheppard HW, et al. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: Immunologic and virologic characteristics. J Infect Dis 1991;163:959-65.
27. Zhu T, Mo II, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 1993;261:1 179-81.
28. Brinchmann JE, Gaudernack G, Vartdal F. In vitro replication of HIV-1 in naturally infected CD4+ T cells is inhibited by rIFNa2 and by a soluble factor secreted by activated CD8+ T cells, but not by rIFN0, rIFN7, or recombinant tumor necrosis factor-a. J AIDS 1991;4:480-8.
29. Wiviott LD, Walker CM, Levy JA. CD8+ lymphocytes suppress HIV production by autologous CD4+ cells without eliminating the infected cells from culture. Cell Immunol 1990;128:628-34.